Biomarkers in Alzheimer’s Disease: CSF, PET and Blood-Based Testing

Biomarkers are transforming the diagnosis and management of Alzheimer’s disease. This session provides a comparative overview of cerebrospinal fluid (CSF), PET imaging, and emerging blood-based biomarkers, highlighting their clinical utility, limitations, and future applications.